Related Experiment Video

Updated: Jun 26, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Availability of mechanical circulatory support (MCS) and hospital survival in ST-segment elevation myocardial

Karl Heinrich Scholz1,2,3, Florian Weiser4, Tim Friede4

  • 1Department of Cardiology and Intensive Care, St. Bernward Hospital, Hildesheim, Germany.

European Heart Journal. Acute Cardiovascular Care
|June 25, 2026
PubMed

Insights

Mechanical circulatory support (MCS) availability did not impact hospital survival for ST-elevation myocardial infarction with cardiogenic shock (STEMI-CS) patients. Outcomes were similar in centers with and without MCS, suggesting no survival benefit from MCS availability in this population.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Critical Care Medicine

Background:

  • ST-elevation myocardial infarction with cardiogenic shock (STEMI-CS) is a severe condition where mechanical circulatory support (MCS) may improve survival.
  • It remains unclear whether centers with MCS availability offer better outcomes for STEMI-CS patients compared to those without.

Purpose of the Study:

  • To investigate the association between MCS availability and prognosis in STEMI-CS patients.
  • To compare hospital mortality rates in STEMI-CS patients treated in centers with and without MCS.

Main Methods:

  • Secondary analysis of the prospective FITT-STEMI registry.
  • Comparison of hospital mortality between STEMI-CS patients treated in MCS centers versus non-MCS centers.
  • Statistical analysis including multivariable adjustment and propensity score matching.

Main Results:

  • A total of 5604 STEMI-CS patients were analyzed (2013-2022).
  • Hospital mortality was 44.7% in MCS centers and 45.0% in non-MCS centers (OR 0.985, p=0.820), with no significant difference after adjustments or matching.
  • Patients in MCS centers were younger and less frequently resuscitated, but had longer contact-to-balloon times.

Conclusions:

  • Hospital survival for STEMI-CS patients did not differ significantly between centers with and without MCS availability.
  • The availability of MCS in a center does not appear to influence survival outcomes for STEMI-CS patients in this large registry analysis.
Abstract

Keywords:
Availability of MCSCSMCSMortalityOutcomeSTEMISTEMI-CS

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...